Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Influenza Vaccines Market Growth in 2025?

The market size of influenza vaccines has experienced robust growth lately. It’s projected to expand from $7.35 billion in 2024 to $7.9 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The previous growth can be traced back to readiness for a pandemic, public health campaigns, effectiveness research for vaccines, recommendations from healthcare professionals, and worldwide influenza surveillance.

What Is the Forecast for the Influenza Vaccines Market Size Through 2029?

In the coming years, the influenza vaccines market is projected to experience robust growth. The market size is forecasted to reach $11.02 billion by 2029, with a compound annual growth rate (CAGR) of 8.7%. This growth during the estimated period is likely due to factors such as changes in climate and environment, betterment in healthcare accessibility, emergence of novel influenza variants, advancements in adjuvants and delivery systems, and an increase in healthcare spending. The forecast period may see a rise in trends such as the broader application of mrna vaccine technology, concentrated efforts on pediatric immunizations, measures to control seasonal influenza, improved vaccination rates in developing countries, and customized vaccination approaches.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

What are the Key Market Players in Influenza Vaccines Market and How They’re Evolving?

Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

What Are the Primary Growth Drivers in the Influenza Vaccines Market?

The growth of the influenza vaccine market is anticipated to be driven by an increase in cases of seasonal flu. Seasonal influenza, a respiratory illness caused by influenza viruses, usually occurs at specific times of the year, mostly during colder months. This trend is attributed to a combination of factors including antigenic drift, susceptibility among the population, environmental conditions, insufficient vaccine distribution, and the absence of all-encompassing vaccination. Influenza vaccines play a crucial role in decreasing instances of seasonal flu by offering immunity against the prevalent virus strains. For instance, in November 2023, the US government agency, the Centers for Disease Control and Prevention (CDC), reported roughly 31 million cases of flu-related illnesses, 14 million associated medical visits, 360,000 hospitalizations due to the flu, and 21,000 flu-related deaths during the 2022-2023 flu season. Hence, the escalating occurrence of influenza seasons is fueling the expansion of the influenza vaccines market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

What Are the Leading Segments in the Global Influenza Vaccines Industry?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

What Are the Key Market Trends in the Influenza Vaccines Industry?

The rise in sophisticated vaccine production technology is becoming a pivotal trend in the influenza vaccine industry. Businesses in this sector are increasingly leveraging these advanced processes to maintain their market stance. For example, GlaxoSmithKline PLC., a British pharmaceutical and biotech firm, rolled out a Multi Antigen Presenting System (MAPS) for vaccine creation in January 2023. This cutting-edge approach offers a fresh perspective on generating potent vaccines against bacterial and viral threats. Importantly, this technology accelerates the development of vaccines, proving essential in the event of an epidemic or pandemic outbreak.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

What Is the Regional Outlook for the Influenza Vaccines Market?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11935

This Report Delivers Insight On:

1. How big is the influenza vaccines market, and how is it changing globally?

2. Who are the major companies in the influenza vaccines market, and how are they performing?

3. What are the key opportunities and risks in the influenza vaccines market right now?

4. Which products or customer segments are growing the most in the influenza vaccines market?

5. What factors are helping or slowing down the growth of the influenza vaccines market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model